Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (10215)
All Articles published online
|
Publishing Process of This Article
|
Jul 28, 2020 (publication date) through Nov 23, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Mpilla GB, Philip PA, El-Rayes B, Azmi AS. Pancreatic neuroendocrine tumors: Therapeutic challenges and research limitations. World J Gastroenterol 2020; 26(28): 4036-4054 [PMID: 32821069 DOI: 10.3748/wjg.v26.i28.4036] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v26/i28/4036.htm |
| Number | Citing Articles |
| 1 |
X. Liu, B. Chen, J. Chen, Z. Su, S. Sun. The incidence, prevalence, and survival analysis of pancreatic neuroendocrine tumors in the United States. Journal of Endocrinological Investigation 2022; 46(7): 1373 doi: 10.1007/s40618-022-01985-2
|
| 2 |
Zhen Yang, Dongsheng Zhang, Guangjun Shi. Reappraisal of a 2-cm Cutoff Size for the Management of Nonfunctional Pancreatic Neuroendocrine Tumors: A Population-Based Study. Frontiers in Endocrinology 2022; 13 doi: 10.3389/fendo.2022.928341
|
| 3 |
Yuan Zhou, Maoen Pan, Ronggui Lin, Heguang Huang. Advances in hydrogel materials applied to pancreatic-related diseases. Journal of Pancreatology 2024; 7(3): 222 doi: 10.1097/JP9.0000000000000158
|
| 4 |
Bor-Shiuan Shyr, Bor-Uei Shyr, Shih-Chin Chen, Yi-Ming Shyr, Shin-E Wang. Impact of tumor grade on pancreatic neuroendocrine tumors. Asian Journal of Surgery 2022; 45(12): 2659 doi: 10.1016/j.asjsur.2022.01.094
|
| 5 |
Intelligent Systems Design and Applications. Lecture Notes in Networks and Systems 2024; 1046: 20 doi: 10.1007/978-3-031-64813-7_3
|
| 6 |
Bokyung Ahn, Joo Young Kim, Seung-Mo Hong. Combined Infiltrative Macroscopic Growth Pattern and Infiltrative Microscopic Tumor Border Status Is a Novel Surrogate Marker of Poor Prognosis in Patients With Pancreatic Neuroendocrine Tumor. Archives of Pathology & Laboratory Medicine 2023; 147(1): 100 doi: 10.5858/arpa.2021-0475-OA
|
| 7 |
Mengfei Fu, Li Yu, Liu Yang, Yang Chen, Xiao Chen, Qinyu Hu, Hui Sun. Gender differences in pancreatic neuroendocrine neoplasms: A retrospective study based on the population of Hubei Province, China. Frontiers in Endocrinology 2022; 13 doi: 10.3389/fendo.2022.885895
|
| 8 |
Nian Guo, Zhen Liang, Li Jiao Xiong. Clinicopathological characteristics, survival outcomes and prognostic factors in the cT1N0M0 pancreatic neuroendocrine tumors: A SEER-based study. Medicine 2022; 101(41): e31019 doi: 10.1097/MD.0000000000031019
|
| 9 |
Feiyu Lu, Mujie Ye, Chunhua Hu, Jinhao Chen, Lijun Yan, Danyang Gu, Lin Xu, Ye Tian, Jianan Bai, Qiyun Tang. FABP5 regulates lipid metabolism to facilitate pancreatic neuroendocrine neoplasms progression via FASN mediated Wnt/β‐catenin pathway. Cancer Science 2023; 114(9): 3553 doi: 10.1111/cas.15883
|
| 10 |
Jessica Wedig, Shrina Jasani, Debasmita Mukherjee, Hannah Lathrop, Priya Matreja, Timothy Pfau, Liliana D’Alesio, Abigail Guenther, Lexie Fenn, Morgan Kaiser, Molly A. Torok, Jake McGue, Gina M. Sizemore, Anne M. Noonan, Mary E. Dillhoff, Bradley W. Blaser, Timothy L. Frankel, Stacey Culp, Phil A. Hart, Zobeida Cruz-Monserrate, Thomas A. Mace. CD200 is overexpressed in the pancreatic tumor microenvironment and predictive of overall survival. Cancer Immunology, Immunotherapy 2024; 73(6) doi: 10.1007/s00262-024-03678-6
|
| 11 |
Wei Li, Chao Xu, Zhaoxiang Ye. Prediction of Pancreatic Neuroendocrine Tumor Grading Risk Based on Quantitative Radiomic Analysis of MR. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.758062
|
| 12 |
Angela Ragone, Alessia Salzillo, Annamaria Spina, Silvio Naviglio, Luigi Sapio. Integrating Gemcitabine-Based Therapy With AdipoRon Enhances Growth Inhibition in Human PDAC Cell Lines. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.837503
|
| 13 |
Zhen Yang, Guangjun Shi. Comparative outcomes of pancreatic neuroendocrine neoplasms: A population-based analysis of the SEER database. European Journal of Surgical Oncology 2022; 48(10): 2181 doi: 10.1016/j.ejso.2022.05.016
|
| 14 |
莹 冯. Comparison of Imaging Features of Hypovascular and Hypervascular Pancreatic Neuroendocrine Neoplasm. Advances in Clinical Medicine 2024; 14(05): 1756 doi: 10.12677/acm.2024.1451613
|
| 15 |
Karolina Skubisz, Krzysztof Dąbkowski, Emilia Samborowska, Teresa Starzyńska, Anna Deskur, Filip Ambrozkiewicz, Jakub Karczmarski, Mariusz Radkiewicz, Katarzyna Kusnierz, Beata Kos-Kudła, Tadeusz Sulikowski, Patrycja Cybula, Agnieszka Paziewska. Serum Metabolite Biomarkers for Pancreatic Tumors: Neuroendocrine and Pancreatic Ductal Adenocarcinomas—A Preliminary Study. Cancers 2023; 15(12): 3242 doi: 10.3390/cancers15123242
|
| 16 |
Weixuan Liu, Bairui Zhang, Tao Liu, Juntao Jiang, Yong Liu. Artificial Intelligence in Pancreatic Image Analysis: A Review. Sensors 2024; 24(14): 4749 doi: 10.3390/s24144749
|
| 17 |
Faten Cherchir, Ines Naceur, Ahmed Anas Haouari, Tayssir Ben Achour, Hajer Ben Mansour, Khadija Bellil, Fatma Said, Mohamed Habib Houman. Unilateral pseudouveitis revealing a pancreatic neuroendocrine carcinoma: A case report. Clinical Case Reports 2022; 10(3) doi: 10.1002/ccr3.5563
|
| 18 |
Mujie Ye, Feiyu Lu, Danyang Gu, Bingyan Xue, Lin Xu, Chuanhua Hu, Jinhao Chen, Ping Yu, Hongxia Zheng, Yue Gao, Jianhua Wang, Qiyun Tang. Hypoxia exosome derived CEACAM5 promotes tumor‐associated macrophages M2 polarization to accelerate pancreatic neuroendocrine tumors metastasis via MMP9. The FASEB Journal 2024; 38(13) doi: 10.1096/fj.202302489RRR
|
| 19 |
Zhen Yang, Jie Liang, Kaiming Leng, Guangjun Shi. Survival Benefit of Surgical Resection for Pancreatic Neuroendocrine Tumors With Oligometastatic Liver Metastasis: A Retrospective and Propensity Score-Matching Analysis. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.903560
|
| 20 |
Xinchao Ban, Shengwei Mo, Zhaohui Lu, Congwei Jia, Huilin Shao, Xiaoyan Chang, Xinxin Mao, Yue Zhang, Junyi Pang, Yuhan Zhang, Shuangni Yu, Jie Chen. Expression and methylation status of MMR and MGMT in well-differentiated pancreatic neuroendocrine tumors and potential clinical applications. Endocrine 2022; 77(3): 538 doi: 10.1007/s12020-022-03102-y
|
| 21 |
Li Quan, Yongkang Liu, Wenjing Cui, Xinru Wang, Weixiao Zhang, Zhongqiu Wang, Chuangen Guo, Chao Lu, Feixiang Hu, Xiao Chen. The associations between serum high-density lipoprotein cholesterol levels and malignant behavior in pancreatic neuroendocrine neoplasms. Lipids in Health and Disease 2022; 21(1) doi: 10.1186/s12944-022-01669-z
|
| 22 |
Hai-Feng Hu, Yu-Heng Hu, Xiao-Wu Xu, Zeng Ye, Xin Lou, Wu-Hu Zhang, Xue-Min Chen, Yue Zhang, Xian-Jun Yu, He-Li Gao, Jun-Yan Xu, Shun-Rong Ji. Role of Somatostatin Receptor 2 in Nonfunctional Pancreatic Neuroendocrine Tumors. Pancreas 2022; 51(10): 1404 doi: 10.1097/MPA.0000000000002199
|
| 23 |
Ramazan GÜNDOĞDU, Serkan ERKAN, Hakan YABANOĞLU, M. Eda ERTÖRER, Esra Zeynep COŞKUNOĞLU, Fatma ÖZARSLAN. Pankreas Nöroendokrin Tümörlerinin Cerrahi Tedavisinde 11 Yıllık Tek Merkez Deneyimi. Harran Üniversitesi Tıp Fakültesi Dergisi 2022; 19(2): 309 doi: 10.35440/hutfd.1126786
|
| 24 |
Mengfei Fu, Li Yu, Liu Yang, Yang Chen, Xiao Chen, Qinyu Hu, Hui Sun. Predictive value of the preoperative prognostic nutritional index for postoperative progression in patients with pancreatic neuroendocrine neoplasms. Frontiers in Nutrition 2022; 9 doi: 10.3389/fnut.2022.945833
|
| 25 |
J. E. Machado-Alba, M. E. Machado-Duque, A. Gaviria-Mendoza, I. N. Arsof-Saab, C. A. Castellanos-Moreno, L. Botero, L. Triana. Prescription patterns of somatostatin analogs in patients with acromegaly and neuroendocrine tumors. Journal of Endocrinological Investigation 2022; 46(1): 27 doi: 10.1007/s40618-022-01875-7
|
| 26 |
Yu Chen, Tatsuki Yamamoto, Yura Takahashi, Tomoka Moro, Tomoko Tajima, Yukiko Sakaguchi, Naoaki Sakata, Akihiko Yokoyama, Susumu Hijioka, Akane Sada, Yuko Tabata, Rieko Ohki. Metabolic intervention by low carbohydrate diet suppresses the onset and progression of neuroendocrine tumors. Cell Death & Disease 2023; 14(9) doi: 10.1038/s41419-023-06123-1
|
| 27 |
Agnes Bocian-Jastrzębska, Anna Malczewska-Herman, Violetta Rosiek, Beata Kos-Kudła. Assessment of the Role of Leptin and Adiponectinas Biomarkers in Pancreatic Neuroendocrine Neoplasms. Cancers 2023; 15(13): 3517 doi: 10.3390/cancers15133517
|
| 28 |
Samuel Frey, Eric Mirallié, Maëlle Le Bras, Nicolas Regenet. What Are the Place and Modalities of Surgical Management for Pancreatic Neuroendocrine Neoplasms? A Narrative Review. Cancers 2021; 13(23): 5954 doi: 10.3390/cancers13235954
|
| 29 |
Silke D. Werle, Nensi Ikonomi, Ludwig Lausser, Annika M. T. U. Kestler, Felix M. Weidner, Julian D. Schwab, Julia Maier, Malte Buchholz, Thomas M. Gress, Angelika M. R. Kestler, Hans A. Kestler. A systems biology approach to define mechanisms, phenotypes, and drivers in PanNETs with a personalized perspective. npj Systems Biology and Applications 2023; 9(1) doi: 10.1038/s41540-023-00283-8
|
| 30 |
Jianbo Li, Long Huang, Chengyu Liao, Guozhong Liu, Yifeng Tian, Shi Chen. Two machine learning-based nomogram to predict risk and prognostic factors for liver metastasis from pancreatic neuroendocrine tumors: a multicenter study. BMC Cancer 2023; 23(1) doi: 10.1186/s12885-023-10893-4
|
| 31 |
Fei Wang, Jihyun Ma, Nan Zhao, Chi Lin, Haixing Jiang. Racial Disparities in Clinical Features and Survival Outcomes among Patients with Pancreatic Neuroendocrine Tumor: A Contemporary SEER Database Analysis. Oncologie 2022; 24(4): 865 doi: 10.32604/oncologie.2022.025447
|